Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs

Pharmacy World and Science

Volumn 28, Issue 4, 2006, Pages 194-198

  Dhippayom, Teerapon ^a   Walker, Roger ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b PUBLIC HEALTH WALES   (United Kingdom)

Author keywords

Omeprazole; OTC; Over the counter; Prescribing; Reclassification; Ulcer healing drugs

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ARTICLE; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG MARKETING; HUMAN; LOWEST INCOME GROUP; PHARMACY; PRESCRIPTION; PRIMARY HEALTH CARE; ULCER HEALING; UNITED KINGDOM;

ANTI-ULCER AGENTS; DRUG INDUSTRY; DRUG UTILIZATION REVIEW; DRUGS, NON-PRESCRIPTION; HEALTH SERVICES NEEDS AND DEMAND; HISTAMINE H2 ANTAGONISTS; HUMANS; MARKETING; OMEPRAZOLE; PRESCRIPTIONS, DRUG; PRIMARY HEALTH CARE; PROTON PUMPS; RETROSPECTIVE STUDIES; TABLETS; TIME FACTORS; ULCER; UNEMPLOYMENT; WALES;

EID: 33750534764     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9031-9     Document Type: Article

References (15)

1. Medicines, ethics & practice: a guide for pharmacists. The Royal Pharmaceutical Society of Great Britain, London, 2003.
2. Blenkinsopp J. Out of the dispensary and into the pharmacy - POM-to-P switching. Pharm J 2004;272:508-9.
3. Cohen JP, Paquette C, Cairns CP. Switching prescription drugs to over the counter. BMJ 2005;330:39-41.
4. Ryan M, Yule B (1990) Switching drugs from prescription-only to over-the-counter availability: economic benefits in the United Kingdom. Health Policy 16:233-9.
5. Bond C. POM to P - implications for practice pharmacists. Prim Care Pharm 2002;2:5-7.
6. Omeprazole goes over-the-counter as Zanprol. Pharm J 2004;272: 305.
7. Ryan M, Birch S. Charging for health care: evidence on the utilisation of NHS prescribed drugs. Soc Sci Med 1991;33:681-7.
8. Jones I, Britten N. Why do some patients not cash their prescriptions? Br J Gen Pract 1998;48:903-5.
9. Senior ML, Williams H, Higgs G. Morbidity, deprivation and drug prescribing: factors affecting variations in prescribing between doctors' practices. Health Place 2003;9:281-9.
10. Williams D, Teljeur C, Bennett K, Kelly A, Feely J. Influence of material deprivation on prescribing patterns within a deprived population. Eur J Clin Pharmacol 2003;59:559-63.
11. Christensen R. Analysis of variance, design and regression: applied statistical methods. Chapman & Hall, London, 1998.
12. Bellingham C. Overhaul of POM-to-P reclassification could mean big changes for pharmacy. Pharm J 2002;268:131-3.
13. Royal Pharmaceutical Society of Great Britain. Practice guidance: OTC omeprazole, May 2004. http:/www.rpsgb.org/pdfs.otcomeprazoleguide.pdf (25 Dec 2005)
14. 2-receptor antagonists. Med Care 1999;37:424-30.
15. Bellingham C. To switch or not: pharmacists opinions. Pharm J 2002;268:607.